Oncolys BioPharma Inc. | Cash Flow
Fiscal year is January-December. All values JPY Thousands.
2013
2014
2015
2016
2017
2018
Net Income before Extraordinaries
633,193.00
737,106.00
854,701.00
928,344.00
1,087,185.00
1,230,105
Depreciation, Depletion & Amortization
17,139.00
15,885.00
16,764.00
15,364.00
1,162.00
1,709
Other Funds
-
-
3,280.00
13,432.00
-
18,213
Funds from Operations
606,842.00
748,995.00
849,511.00
851,810.00
1,084,132.00
1,246,606
Changes in Working Capital
8,314.00
65,494.00
93,755.00
51,614.00
12,708.00
59,027
Net Operating Cash Flow
598,528.00
814,489.00
755,756.00
903,424.00
1,096,840.00
1,187,579
Capital Expenditures
678.00
23,085.00
4,175.00
20,994.00
1,436.00
Sale of Fixed Assets & Businesses
-
9,877.00
-
913.00
-
Purchase/Sale of Investments
112,138.00
3,392,629.00
1,758,983.00
288,290.00
144,179.00
Net Investing Cash Flow
110,458.00
3,408,702.00
1,754,808.00
256,627.00
131,662.00
Issuance/Reduction of Debt, Net
212,171.00
4,931.00
123,460.00
43,886.00
63,873.00
Net Financing Cash Flow
5,440,081.00
233.00
120,060.00
6,423.00
1,476,503.00
Net Change in Cash
4,980,755.00
4,222,144.00
877,786.00
641,259.00
503,461.00
Free Cash Flow
599,206.00
837,574.00
755,756.00
924,418.00
1,098,276.00
Net Assets from Acquisitions
-
-
-
10,173.00
-
Other Sources
-
-
-
398,591.00
-
Change in Capital Stock
5,227,910.00
5,164.00
120.00
36,878.00
1,412,630.00
Exchange Rate Effect
28,744.00
1,280.00
1,206.00
885.00
7,864.00
Other Uses
1,002.00
2,865.00
-
400,000.00
11,079.00
About Oncolys BioPharma
View Profile
